Skip to main content
TipRanks
Go Ultimate75% OFF

Global X Genomics & Biotechnology UCITS ETF (CH:GNOM) Price & Chart

CH:GNOM ETF Chart & Stats

CHF 9.21
At close: 4:00 PM EST
CHF9CHF10Aug 17Aug 31Sep 14Sep 28Oct 12Oct 28Nov 11
Day’s Range
CHF 9.20 - CHF 9.21
52-Week Range
CHF 5.91 - CHF 10.69
Previous Close
CHF 9.45
Volume
0
Average Volume (3M)
885
AUM
138.99M
NAV
11.00
Expense Ratio
0.50%
Holdings Count
51
Beta
0.91
Inception Date
Nov 02, 2021
Last Dividend Ex-Date
N/A
Dividend Yield
N/A
Shares Outstanding
11,780,000
Standard Deviation
N/A

ETF Overview

Global X Genomics & Biotechnology UCITS ETF

The Global X Genomics & Biotechnology UCITS ETF, trading under the ticker DE:GN0M, offers investors a dynamic opportunity to delve into the cutting-edge world of genomic advancements. As a sector-focused ETF, it specifically targets the burgeoning niche of genomics and biotechnology, positioning itself at the forefront of medical innovation and technological development. This fund is meticulously designed to capture the growth potential of companies that are revolutionizing healthcare through genetic research, biotechnological breakthroughs, and the development of novel therapies. By investing in DE:GN0M, stakeholders gain exposure to a diversified portfolio of industry leaders and pioneering firms that are driving the future of medicine and personalized healthcare. This ETF not only reflects the transformative impact of genomic sciences but also aligns with the growing demand for thematic investment strategies focused on sectors poised for substantial long-term growth.

CH:GNOM ETF News

CH:GNOM ETF FAQ

What was CH:GNOM’s price range in the past 12 months?
CH:GNOM’s lowest price in the past 12 months was CHF 5.91 and its highest was CHF 10.69.
What is the AUM of CH:GNOM?
As of Nov 13, 2026, the AUM of CH:GNOM is CHF138.99M.
Is CH:GNOM overvalued?
Based on Wall Street analyst price targets for CH:GNOM’s holdings, CH:GNOM’s price is currently undervalued.
How many shares outstanding does CH:GNOM have?
CH:GNOM has 11,780,000 shares outstanding.